L'IMMUNOTHERAPIE ANTICANCEREUSE: BASES IMMUNOLOGIQUES, REALITE ET ESPOIRS

P. Y. Dietrich; F. Farace; A. Caignard; B. Escudier; F. Triebel

L'IMMUNOTHERAPIE ANTICANCEREUSE: BASES IMMUNOLOGIQUES, REALITE ET ESPOIRS

P. Y. Dietrich, F. Farace, A. Caignard, B. Escudier, F. Triebel

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

Résumé

The use of the immune system for the treatment of cancer is still debated. Recent advances in antigen presentation and recognition mechanisms, and the characterization of tumor-specific antigens generating a T cell response are crucial steps for the stimulation of research in this direction. These advances should allow the development of selective immunotherapy, either passive (infusion of lymphocytes with specific recognition of autologous tumor) or active (vaccination), and the evaluation of this new approach in cancer treatment strategies.

langue originale	Anglais
Pages (de - à)	584-600
Nombre de pages	17
journal	Bulletin du Cancer
Volume	80
Numéro de publication	7
état	Publié - 1 janv. 1993

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{9e291c52cd0d48abb23fbd46fb29018c,

title = "L'IMMUNOTHERAPIE ANTICANCEREUSE: BASES IMMUNOLOGIQUES, REALITE ET ESPOIRS",

abstract = "The use of the immune system for the treatment of cancer is still debated. Recent advances in antigen presentation and recognition mechanisms, and the characterization of tumor-specific antigens generating a T cell response are crucial steps for the stimulation of research in this direction. These advances should allow the development of selective immunotherapy, either passive (infusion of lymphocytes with specific recognition of autologous tumor) or active (vaccination), and the evaluation of this new approach in cancer treatment strategies.",

keywords = "Immunotherapy, Interleukin-2, Lymphocyte",

author = "Dietrich, {P. Y.} and F. Farace and A. Caignard and B. Escudier and F. Triebel",

year = "1993",

month = jan,

day = "1",

language = "English",

volume = "80",

pages = "584--600",

journal = "Bulletin du Cancer",

issn = "0007-4551",

number = "7",

}

TY - JOUR

T1 - L'IMMUNOTHERAPIE ANTICANCEREUSE

T2 - BASES IMMUNOLOGIQUES, REALITE ET ESPOIRS

AU - Dietrich, P. Y.

AU - Farace, F.

AU - Caignard, A.

AU - Escudier, B.

AU - Triebel, F.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - The use of the immune system for the treatment of cancer is still debated. Recent advances in antigen presentation and recognition mechanisms, and the characterization of tumor-specific antigens generating a T cell response are crucial steps for the stimulation of research in this direction. These advances should allow the development of selective immunotherapy, either passive (infusion of lymphocytes with specific recognition of autologous tumor) or active (vaccination), and the evaluation of this new approach in cancer treatment strategies.

AB - The use of the immune system for the treatment of cancer is still debated. Recent advances in antigen presentation and recognition mechanisms, and the characterization of tumor-specific antigens generating a T cell response are crucial steps for the stimulation of research in this direction. These advances should allow the development of selective immunotherapy, either passive (infusion of lymphocytes with specific recognition of autologous tumor) or active (vaccination), and the evaluation of this new approach in cancer treatment strategies.

KW - Immunotherapy

KW - Interleukin-2

KW - Lymphocyte

UR - http://www.scopus.com/inward/record.url?scp=0027633641&partnerID=8YFLogxK

M3 - Review article

C2 - 8204939

AN - SCOPUS:0027633641

SN - 0007-4551

VL - 80

SP - 584

EP - 600

JO - Bulletin du Cancer

JF - Bulletin du Cancer

IS - 7

ER -